Curis Inc

NASDAQ: CRIS
$5.91
-$0.02 (-0.3%)
Closing Price on September 20, 2024

CRIS Chart and Intraday Price

CRIS Company Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 94.36M USD
Shares Outstanding 5,894,100
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.

CRIS Articles

Top Analyst Upgrades and Downgrades: AMD, Cisco, eHealth, iHeart Media, Intel, Playtika, ViacomCBS, Williams-Sonoma and More
Thursday's top analyst upgrades and downgrades included AllianceBernstein, AMD, Cisco, eHealth, iHeart Media, Intel, Playtika, ViacomCBS and Williams-Sonoma.
Lee Jackson
Published:

The Hits Keep Coming With Curis's Secondary Offering
Curis shares are on the run again. This time it’s due to a secondary offering.
Chris Lange
Published:

This Curis Cancer Study Is a Big Hit
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.
Chris Lange
Published: